For the best experience, please view the website in portrait mode.

News

CardioPrecision Launches CoreVista® Devices for Endoscopic Vessel Harvesting (EVH)

01.09.2021

CardioPrecision Ltd, a technology company developing medical devices for the treatment of structural heart disease and cardiothoracic interventions, has recently launched its suite of CoreVista® devices for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) surgery. EVH is a technique whereby bypass conduits are harvested endoscopically from the limbs thro...

Read More

CardioPrecision Secures Further Investment

24.07.2020

CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic interventions, received further investment. The equity financing was led by existing investors and the Scottish Investment Bank, the investment arm of Scottish Enterprise. CardioPrecision’s patented CoreVista® Technology facilitates access to the chest through a sho...

Read More

CardioPrecision Announces New TMVR Method Patent in the US

08.10.2019

CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic intervention, announces the issuance of its latest patent ‘New Method and System for Transcatheter Intervention’ from the United States Patent and Trademark Office. CardioPrecision Founder and Chief Medical Officer, Mr Fraser Sutherland, MD, commented: “ We are ...

Read More

CardioPrecision Ltd is certified to EN ISO 13485:2016

Cardio Precision Logo